Clinical Trial

Clareon PanOptix Versus AcrySof PanOptix : Prospective Study Comparing Contrast Sensitivity

Study acronym: CLAYRE
Recruiting
View on ClinicalTrials.gov →
Summary
Retrospective, comparative, interventional, randomized, single-center study, contralateral (the patient's 2 eyes will be implanted: 1 CPO and the other APO) Patients presenting for cataract surgery with a request for presbyopia correction and managed as part of routine clinical practice. The main aim of the study is to demonstrate that contrast sensitivity is better with the Clareon PanOptix (CPO) intraocular lens (IOL) compared with the AcrySof PanOptix (APO) IOL 3 months after implantation.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-28.
Status change: Not Yet Recruiting → Recruiting 2026-03-25
Trial Details
NCT Number NCT07158177
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Collaborators: Alcon Research, URC-CIC Paris Descartes Necker Cochin
Conditions Cataract and IOL Surgery
Enrollment 40 participants
Start Date 2025-10-01
Primary Completion 2026-10-15 (estimated)
Study Completion 2026-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-03-30